Omeros Corp (OMER)
3.45
+0.14
(+4.23%)
USD |
NASDAQ |
May 17, 16:00
3.445
0.00 (0.00%)
After-Hours: 20:00
Omeros Cash from Financing (Quarterly): 98.43M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 98.43M |
| December 31, 2023 | -104.95M |
| September 30, 2023 | -0.483M |
| June 30, 2023 | -0.26M |
| March 31, 2023 | -0.388M |
| December 31, 2022 | -0.651M |
| September 30, 2022 | 124.84M |
| June 30, 2022 | -0.099M |
| March 31, 2022 | 0.161M |
| December 31, 2021 | -0.81M |
| September 30, 2021 | 0.478M |
| June 30, 2021 | 0.855M |
| March 31, 2021 | 5.796M |
| December 31, 2020 | -0.163M |
| September 30, 2020 | 172.45M |
| June 30, 2020 | -0.151M |
| March 31, 2020 | 2.399M |
| December 31, 2019 | 56.48M |
| September 30, 2019 | 3.058M |
| June 30, 2019 | 1.309M |
| March 31, 2019 | -0.146M |
| December 31, 2018 | 30.09M |
| September 30, 2018 | 3.714M |
| June 30, 2018 | 46.70M |
| March 31, 2018 | 0.544M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.108M |
| September 30, 2017 | 68.37M |
| June 30, 2017 | 4.417M |
| March 31, 2017 | 1.096M |
| December 31, 2016 | 8.801M |
| September 30, 2016 | 37.47M |
| June 30, 2016 | 20.82M |
| March 31, 2016 | 1.609M |
| December 31, 2015 | 9.917M |
| September 30, 2015 | -1.786M |
| June 30, 2015 | -1.957M |
| March 31, 2015 | 80.65M |
| December 31, 2014 | 0.813M |
| September 30, 2014 | 0.272M |
| June 30, 2014 | 0.539M |
| March 31, 2014 | 49.23M |
| December 31, 2013 | 5.466M |
| September 30, 2013 | 0.022M |
| June 30, 2013 | 16.14M |
| March 31, 2013 | 0.022M |
| December 31, 2012 | 4.912M |
| September 30, 2012 | 30.85M |
| June 30, 2012 | -1.415M |
| March 31, 2012 | -1.376M |
| December 31, 2011 | -0.881M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-104.95M
Minimum
Dec 2023
172.45M
Maximum
Sep 2020
17.91M
Average
0.3195M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.78M |
| Cash from Investing (Quarterly) | -61.92M |
| Free Cash Flow | -142.08M |
| Free Cash Flow Per Share (Quarterly) | -0.7115 |
| Free Cash Flow Yield | -66.71% |